Abstract: There are pharmacological, interventional, laser myocardial revascularization, and coronary artery bypass grafting treatments for cardiovascular disease. Percutaneous transluminal coronary angioplasty (PTCA) is an intermediate human treatment for coronary artery disease developed in recent years using high-tech technology. Cardiovascular diseases are treated with medications, interventions, laser myocardial revascularization, and coronary artery bypass grafting. So what is the best treatment for cardiovascular disease? Interventionaltreatment is an emerging treatment method between surgical and medical treatment, including intravascular and non-vascular interventions. After more than 30 years of development, it is now known as one of the three pillar disciplines along with surgery and internal medicine. In simple terms, interventional therapy is the least invasive treatment method to treat the lesion locally under the guidance of imaging equipment (angiography, fluoroscopy, CT, MR, B-ultrasound) without opening the lesion and exposing it by making a tiny channel of several millimeters in diameter in the blood vessel or skin, or through the body’s original pipeline. Thrombolytic therapy is a modern pathology that has confirmed that the acute occlusion of the vascular lumen caused by the acute formation of thrombus on the basis of coronary atherosclerosis, resulting in the interruption of blood flow in the coronary arteries, is the pathological basis of AMI. Thrombolytic therapy is the intravenous infusion of urokinase, streptokinase and other thrombolytic drugs to open the blood vessels and restore myocardial perfusion. Since its emergence in the mid-1980s, this method has established its position in saving AMI, and is one of the major advances in the history of AMI treatment, and has been popularized to all primary hospitals in China. It is rapidly effective, safe, simple, and easy to perform, greatly shortening the patient’s hospitalization time, reducing medical costs, lowering mortality, and improving the patient’s quality of life. Percutaneous transluminal coronary angioplasty (PTCA) is an intermediate human treatment for coronary heart disease developed in recent years using high-tech technology, and it is applicable to the treatment of all stages of coronary heart disease. A special small catheter is inserted from the arterial vessels of the patient’s extremities to the opening of the coronary artery under the guidance of X-ray, and a coronary angiogram is taken first. After the location, nature and severity of the lesion are clarified, a catheter with a balloon at the front end is sent to the lesion and the balloon is inflated outside the body to dilate the diseased vessel. If the effect of balloon dilation alone is not satisfactory, an alloy stent with laser polishing and cutting is usually delivered to the lesion to support the vessel and achieve adequate opening of the vessel. For some vessels that are not suitable for simple PTCA with stenting, measures such as targeted coronary endoplaque spinning (DCA) can also be used. Compared with coronary artery bypass grafting, PTCA has the advantages of being open-hearted, non-general anesthesia, and minimally invasive to the patient. The degree of revascularization is much higher than that of thrombolytic therapy, but in some patients it is less effective than coronary artery bypass grafting, and there is a possibility of postoperative restenosis in about l5 % of patients. Coronary artery bypass grafting (CABG) is also known as “coronary artery bypass grafting”. It is performed by taking a vein or artery from the patient that does not affect physiological function, connecting one end to the root of the aorta and the other end to the distal end of the coronary artery lesion, bypassing the diseased part of the coronary artery and acting as a “bridge” to the distal myocardium. CABG not only solves the problems faced by drug therapy and PTCA in the treatment of coronary artery disease, such as lesions at branches, multiple branches, and unprotected left main artery lesions, but is also the most complete and thorough way to reconstruct blood flow. Patients can return to normal work 1-2 months after bypass surgery, and the elimination rate of their early angina symptoms is as high as 85%-95%. More than 65% of patients are angina-free for 5 years after surgery, with a 5-year survival rate of 93% and a 10-year survival rate of 80%. Even for those who have lesions in 3 coronary arteries with impaired cardiac function, the 7-year survival rate can reach 90%, compared to 37% for those who receive drug therapy alone. In the past, the saphenous vein was used as the bridge vessel, but with the improvement and development of surgical techniques and instruments, surgeons are now more willing to use arteries with higher long-term patency and survival rates and better prognosis, such as the internal mammary artery and the flexural artery, as the bridge vessel. The procedure generally requires general anesthesia, extracorporeal circulation and temporary cardiac arrest, which is the main concern of patients about this treatment. In fact, it was Russian President Boris Yeltsin who underwent saphenous vein bypass surgery in November 1999. As the president of a major country with a “nuclear button” in his hand and the safety of the world at stake, he gladly underwent the procedure and “easily” resigned at the beginning of the year, which eloquently illustrates that the procedure has been developed to the highest level. Last year alone, our center completed more than 200 cases of coronary artery bypass grafting, with a success rate of more than 98%. The principle of laser myocardial revascularization (TMR or PMR) is that reptilian hearts do not have coronary arteries, and they rely on the pressure step difference between systole and diastole to press blood into the extensive sinus gaps between the myocardium to perfuse the myocardium with blood. This gap also exists in the human fetal heart, except that after birth it no longer communicates directly with the cardiac chambers or coronary arteries. So, could laser energy be used to create tunnels in the ischemic myocardium and use these tunnels and the sinus gaps that communicate with the laser tunnels to perfuse the ischemic myocardium with blood through the pressure difference between systole and diastole? This was the principle of TMR or PMR as originally envisioned, but current research suggests that the principle is much more complex than originally thought. In the process of treatment, the following points must also be noted: 1. Quit smoking According to medical surveys, the risk of myocardial infarction and sudden death is two times higher in smokers than in nonsmokers. It can be seen that smoking is undoubtedly harmful for patients suffering from heart disease, therefore, smoking when quitting is indisputable. 2, pay attention to diet do not eat meat every day, should eat less fat, cholesterol-rich food, try to control the intake of sugar, eat more fruits and vegetables, eat more fish, can drink milk. 3, adhere to the appropriate physical exercise exercise for heart disease is far more beneficial than harmful. But it must be pointed out that, according to their specific conditions, within their capabilities, the right amount of exercise. 4, open-minded everything to take it easy. Do not be for a little thing, and a lot of anger, to maintain a good mood and mentality. 5, pay attention to rest usually pay attention to the combination of work and rest, to ensure adequate sleep. 6, abstain from sexual intercourse especially during the attack should pay more attention to avoid overexcitement caused by unpredictable, or even life-threatening. Bananas and yogurt have a high potassium content, which helps control blood pressure. The results of a foreign study of 2,600 people followed up, 6 days a week to eat food containing 1 gram of potassium per day, such as a potato, a large banana and 225 grams of milk, 5 weeks after the blood pressure can drop 4 mm Hg. You can also drink more orange juice, which is rich in vitamin C. The higher the level of vitamin C in the blood, the lower the blood pressure. Studies have concluded that vitamin C helps to dilate blood vessels. Taking 60 mg of vitamin C tablets a day or eating more vegetables, lemons and other sour fruits can do the same thing.